side effect

Depression and Chronic Diseases: It Is Time for a Synergistic Mental Health and Primary Care Approach.

Depression and chronic diseases: it is time for a synergistic mental health and primary care approach.

Prim Care Companion CNS Disord. 2013; 15(2):
Voinov B, Richie WD, Bailey RK

Objective: To identify the growing significance of depression as a… Continue reading

OLANZAPINE ACTIVATES HEPATIC MAMMALIAN TARGET of RAPAMYCIN (MTOR): NEW MECHANISTIC INSIGHT INTO METABOLIC DYSREGULATION WITH ATYPICAL ANTIPSYCHOTIC DRUGS.

OLANZAPINE ACTIVATES HEPATIC MAMMALIAN TARGET OF RAPAMYCIN (mTOR): NEW MECHANISTIC INSIGHT INTO METABOLIC DYSREGULATION WITH ATYPICAL ANTIPSYCHOTIC DRUGS.

J Pharmacol Exp Ther. 2013 Aug 7;
Schmidt RH, Jokinen JD, Massey VL, Falkner KC, Shi X, Yin X, Zhang X,… Continue reading

Quetiapine Versus Haloperidol in the Treatment of Delirium: A Double-Blind, Randomized, Controlled Trial.

Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial.

Drug Des Devel Ther. 2013; 7: 657-67
Maneeton B, Maneeton N, Srisurapanont M, Chittawatanarat K

Atypical antipsychotic drugs may have low propensity to induce extrapyramidal side… Continue reading

Advanced Drug Delivery to the Lymphatic System: Lipid-Based Nanoformulations.

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

Int J Nanomedicine. 2013; 8: 2733-44
Khan AA, Mudassir J, Mohtar N, Darwis Y

The delivery of drugs and bioactive compounds via the lymphatic system is complex and dependent on… Continue reading

Advances in Brain Stimulation for Depression.

Advances in brain stimulation for depression.

Ann Clin Psychiatry. 2013 Aug; 25(3): 217-24
Wani A, Trevino K, Marnell P, Husain MM

Major depressive disorder is a common and debilitating psychiatric disorder that negatively impacts a large portion of the… Continue reading

Dopamine Neurons Are Multi-Neurotransmitter Neurons.

Dopamine neurons are multi-neurotransmitter neurons.

Mov Disord. 2013 Aug 7;
Benoit-Marand M

HubMed – addiction

Naltrexone may block euphoria-like placebo effect.

BMJ Case Rep. 2013; 2013:
Samokhvalov AV, Gamaleddin I, Sproule B, Rehm J

Naltrexone is a first-line… Continue reading

Do Optimal Antihypertensive Drug Regimens Allow Blood Pressure Normalization in All Patients With Resistant Hypertension?

Do Optimal Antihypertensive Drug Regimens Allow Blood Pressure Normalization in All Patients With Resistant Hypertension?

Hypertension. 2013 Aug 5;
Waeber B, Feihl F

HubMed – drug

Potassium Channel Openers Increase Aortic Elastic Fiber Formation and Reverse the Genetically Determined… Continue reading

Drug Interactions in Dermatology: What the Dermatologist Should Know.

Drug interactions in dermatology: what the dermatologist should know.

Indian J Dermatol. 2013 Jul; 58(4): 249-54
Coondoo A, Chattopadhyay C

A drug interaction is a process by which a drug or any other substance interacts with another drug and… Continue reading

Comparing the Effectiveness of Acceptance-Based Behavior Therapy and Applied Relaxation on Acceptance of Internal Experiences, Engagement in Valued Actions and Quality of Life in Generalized Anxiety Disorder.

Comparing the effectiveness of acceptance-based behavior therapy and applied relaxation on acceptance of internal experiences, engagement in valued actions and quality of life in generalized anxiety disorder.

J Res Med Sci. 2013 Feb; 18(2): 118-22
Zargar F, Farid AA,… Continue reading

[Buprenorphine Transdermal Patch (Norspan Tape)].

[Buprenorphine transdermal patch (Norspan tape)].

Masui. 2013 Jul; 62(7): 799-807
Hamaguchi S, Ikeda T

Buprenorphine is a chemically synthesized opioid characterized as the partial mu agonist and kappa antagonist, and transdermal buprenorphine patch will be considered useful as a… Continue reading